OTOA Polyclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: BS65666-50, BS65666-100

Product: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Swiss-Prot: Q7RTW8

Host: Rabbit

Reactivity: Human, Mouse, Rat,

Applications: WB

All Applications: WB=1:500-2000

Background: Otoancorin, also known as OTOA, CT108 or DFNB22, is a 1,153 amino acid protein belonging to the stereocilin family. Expressed in the inner ear and restricted to the interface between the apical surface of sensory epithelia, otoancorin is suggested to act as an adhesion molecule. Otoancorin ensures the attachment of the inner ear acellular gels to the apical surface of the underlying nonsensory cells. Mutations in the gene encoding otoancorin leads to deafness autosomal recessive type 22 (DFNB22), which is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain or the area of the brain that receives sound information. Existing as three alternatively spliced isoforms, otoancorin is encoded by a gene located on human chromosome 16p12.2.

Purification and Purity: affinity purified by Protein A

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: OTOA Polyclonal Antibody detects endogenous levels of OTOA protein.

Bioworld Molecular Weight: 150 kD

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Sample:
Testis (Mouse) Lysate at 40 ug
Primary: Anti-OTOA at 1/1000 dilution

Alternative Name: Cancer/testis antigen 108; CT108; Deafness, autosomal recessive 22; DFNB22; OTOA; OTOAN_HUMAN; Otoancorin.

Immunogen: KLH conjugated synthetic peptide derived from human OTOA/DFNB22

Conjugate: Unconjugated

Modification: Unmodified